-
1
المؤلفون: Ozkan Kanat, Ozlem Saraydaroglu, Turkkan Evrensel, Ömer Fatih Ölmez, Erdem Cubukcu, Unsal Akcali, Ender Kurt, Osman Manavoglu
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., Çubukçu, Erdem, Ölmez, Ömer Fatih, Saraydaroǧlu, Özlem, Akçalı, Ünsal, Kanat, Özkan, Kurt, Ender, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAH-9701-2021
المصدر: Clinical and Translational Oncology. 13:826-830
مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, Lung Neoplasms, Resistance, Protein function, Cancer staging, Gene, Carboplatin, Carcinoma, Non-Small-Cell Lung, Medicine, Overall survival, Disease free survival, Etoposide, Excision Repair Cross-Complementing 1, General Medicine, Middle Aged, Excision repair cross complementing protein 1, Prognosis, Immunohistochemistry, DNA-Binding Proteins, Lung non small cell cancer, Chemotherapy, Adjuvant, Lung carcinogenesis, Female, Non small cell, Protein determination, Human, medicine.drug, Adult, medicine.medical_specialty, Paclitaxel, Histopathology, Antineoplastic Agents, Article, Disease-Free Survival, Messenger-RNA, Disease association, Survival probability, Internal medicine, Dna-repair, Chemotherapy, Humans, Human tissue, Lung cancer, DNA Repair, Value of Repair, Ribonucleotide Reductases, Aged, Molecular pathology, Cisplatin, Intermethod comparison, business.industry, Protein localization, Follow up, Endonucleases, medicine.disease, Gemcitabine, Cancer survival, respiratory tract diseases, Outcome assessment, Progression free survival, Protein expression, Molecular Profile, Therapy, ERCC1, Excision repair cross-complementing 1, Prediction, business, Non-small-cell lung cancer, Controlled study, Biomarkers
-
2
المؤلفون: Ender Kurt, Osman Manavoglu, Unsal Akcali, Turkkan Evrensel, Kursat Keskin, Ozkan Kanat
المصدر: Lung Cancer. 56:143-144
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cisplatin, Cancer Research, medicine.medical_specialty, Pathology, Necrosis, business.industry, Respiratory disease, Ischemia, respiratory system, medicine.disease, Gastroenterology, Oncology, Docetaxel, Internal medicine, Medicine, Non small cell, medicine.symptom, business, Lung cancer, Complication, therapeutics, neoplasms, medicine.drug
-
3
المؤلفون: Erdem Cubukcu, Cengiz Gebitekin, Unsal Akcali, Ahmet Sami Bayram, Ömer Fatih Ölmez, Turkkan Evrensel
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Cerrahisi Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., Ölmez, Ömer Fatih, Çubukçu, Erdem, Bayram, Ahmet Sami, Akçalı, Ünsal, Evrensel, Türkkan, Gebitekin, Cengiz, AAJ-1027-2021, ABB-7580-2020
المصدر: World Journal of Gastroenterology. 18:662
مصطلحات موضوعية: Male, Oncology, Lung Neoplasms, Survival, Cancer localization, Preoperative evaluation, Colorectal cancer, Metastasis resection, Turkey (republic), Wedge resection, Overall survival, Disease free survival, Liver metastasis, Hazard ratio, Gastroenterology, General Medicine, Middle Aged, Cancer size, Treatment Outcome, Lung metastasis, medicine.anatomical_structure, Surgical resection, Pulmonary metastases, Tertiary health care, Medical history, Adenocarcinoma, Female, Cancer chemotherapy, Metastasectomy, Colorectal Neoplasms, Lung metastases, Human, Adult, medicine.medical_specialty, Brief Article, Clinical article, Tumor differentiation, Prognostic factors, Disease-Free Survival, Article, Postoperative care, Internal medicine, medicine, Humans, Sarcoma, Lung Cancer, Retrospective Studies, Aged, Cancer prognosis, Lymph node metastasis, Lung, Proportional hazards model, business.industry, Carcinoma, Post treatment survival, Prognostic-factors, Retrospective cohort study, medicine.disease, Cancer survival, Confidence interval, Outcome assessment, Carcinoembryonic antigen, Surgery, business, Gastroenterology & hepatology, Controlled study
وصف الملف: application/pdf